Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Looking for participantsNCT06023862What this trial is testingA Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)Who this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more Yonsei University 198
Testing effectiveness (Phase 2)Study completedNCT03180294What this trial is testingBupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerWho this might be right forBreast CarcinomaCervical CarcinomaOvarian Carcinoma+4 more NRG Oncology 230
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06075264What this trial is testingPhase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)Who this might be right forVulvar DiseasesHPV InfectionVulvar HSIL+10 more Frantz Viral Therapeutics, LLC 27
Testing effectiveness (Phase 2)Looking for participantsNCT07433283What this trial is testingCarbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid TumorWho this might be right forTumor, SolidLung CancerPancreas Cancer+4 more Sichuan Enray Pharmaceutical Sciences Company 54
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Study completedNCT00003325What this trial is testingLymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the VulvaWho this might be right forVulvar Cancer Gynecologic Oncology Group 515
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Not applicableStudy completedNCT00504023What this trial is testingTopical Imiquimod in Treating Patients With Recurrent Paget's Disease of the VulvaWho this might be right forVulvar Cancer Memorial Sloan Kettering Cancer Center 8
Testing effectiveness (Phase 2)UnknownNCT00905658What this trial is testingNutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological CancerWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+4 more Centre Oscar Lambret 120
Large-scale testing (Phase 3)Ended earlyNCT00006096What this trial is testingRadiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the VulvaWho this might be right forVulvar Cancer Gynecologic Oncology Group
Early research (Phase 1)Looking for participantsNCT04169763What this trial is testingNelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by SurgeryWho this might be right forStage II Vulvar Cancer AJCC v8Stage III Vulvar Cancer AJCC v8Stage IIIA Vulvar Cancer AJCC v8+3 more M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT04066894What this trial is testingSacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyWho this might be right forLow Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more M.D. Anderson Cancer Center 3
Not applicableUnknownNCT00956670What this trial is testingLymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar CancerWho this might be right forLymphedemaStage IA Cervical CancerStage IA Uterine Corpus Cancer+11 more Gynecologic Oncology Group 1,055
Testing effectiveness (Phase 2)WithdrawnNCT03220009What this trial is testingNivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWho this might be right forCervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02858310What this trial is testingE7 TCR T Cells for Human Papillomavirus-Associated CancersWho this might be right forPapillomavirus InfectionsCervical Intraepithelial NeoplasiaCarcinoma In Situ+2 more National Cancer Institute (NCI) 224
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00476476What this trial is testingErlotinib in Women With Squamous Cell Carcinoma of the VulvarWho this might be right forSquamous Cell Carcinoma Dana-Farber Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT00014599What this trial is testingPaclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the VulvaWho this might be right forVulvar Cancer European Organisation for Research and Treatment of Cancer - EORTC 31